Business · 13/02/2023
Centers for Medicare & Medicaid Services Announces Comment Period for Inflation Reduction Act Initial Program Guidance
The Centers for Medicare & Medicaid Services is seeking public comments on its initial guidance for the Medicare Part B and Part D Prescription Drug Inflation Rebate Program under the Inflation Reduction Act.
Original source language: Federal Register — Health and Human ServicesOpen original release →